Patent details

91320 Product Name: Ranibizumab et ses dérivés pharmaceutiquement acceptables (LUCENTIS®)

Basic Information

Publication number:
91320
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP989179916
Legal Status:
Expired
Application number:
91320
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
26/11/2019
SPC Extension Agent Name:
OFFICE FREYLINGER S.A.
SPC Extension Status:
Granted
SPC Extension Grant Date:
25/02/2021
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/06/374/001
Marketing Authorization Type:
Marketing Authorization Date:
24/01/2007
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
28/02/2007
First Marketing Authorization date:
24/01/2007
Grant date:
30/04/2007
Activation date:
03/04/2018
Publication date:
30/04/2007
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
24/01/2022
SPC Extension Expiration:
24/07/2022
Rejection date:
Withdrawal date:

Owner

From:
28/02/2007
 
 

Name:
GENENTECH INC.
Address:
DNA WAY 1, SOUTH SAN FRANCISCO CA 94080-4990, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
28/02/2007
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
PRESTA Leonard, G.
Address:
United States (US)

2

Name:
LOWMAN Henry, B.
Address:
United States (US)

3

Name:
BACA Manuel
Address:
Australia (AU)

4

Name:
WELLS James, A.
Address:
United States (US)

5

Name:
CHEN Yvonne, Man-Yee
Address:
United States (US)

Publication

Bulletin

1

Bulletin Heading:
SPC3
Bulletin edition number:
2018/06
Publication date:
22/05/2018
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

2

Bulletin Heading:
SPC4
Bulletin edition number:
2019/01
Publication date:
09/01/2019
Description:
Section F : Correction of granted supplementary protection certificates – I9 publication

3

Bulletin Heading:
SPCX1
Bulletin edition number:
2019/13
Publication date:
20/12/2019
Description:
Section G : Applications for extensions for pediatric use – I1E publication

4

Bulletin Heading:
SPCX2
Bulletin edition number:
2021/04
Publication date:
08/03/2021
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
17/03/2021
Last Annual Fee Paid Number:
24
Last Annual Fee Paid Amount:
440 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages
25/03/2016 Incoming Correspondence (Post) 2
26/11/2019 Application Form 4
26/11/2019 General Document 1
25/02/2021 Outgoing Correspondence 1
26/11/2019 General Document 109
27/11/2019 Outgoing Correspondence 1
25/02/2021 Publication 1
31/12/2018 Publication 1
26/11/2019 General Document 2
25/02/2021 Certificate 1
27/11/2019 FNET_DC_FRONTPAGE 1
26/11/2019 General Document 3
27/11/2019 Publication 1
31/12/2018 Outgoing Correspondence 1